Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W. Douglas Pagan


  • Director at Ziopharm Oncology Inc (ZIOP), 2020-01-03
  • Chief Financial Officer at Paratek Pharmaceuticals Inc. (PRTK), 2019-04-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRTK $6.77 2,495 Officer 134,057 2019-02-05 Filing
PRTK $6.76 2,918 Officer 120,302 2018-12-12 Filing
PRTK $8.96 2,784 Officer 123,220 2018-10-15 Filing
PRTK $9.82 7,579 Officer 119,504 2018-10-03 Filing
PRTK $12.70 5,237 Officer 77,083 2018-04-09 Filing